← brief for 2026-10-19 · Slowing decline

The role of finerenone in combination with sodium-glucose cotransporter-2 inhibitors in preventing and/or delaying the progression of diabetic kidney disease in individuals with type 2 diabetes: a scoping review

Article No results yet Not peer reviewed

Key takeaways

This review is mapping out what we know about using two diabetes drugs together. It aims to see if they help slow kidney decline. The review is still in progress, so there are no results yet.

Who did this work

Amanda Peres da Silva Serrano · Carlos Antônio Negrato · Luis Fernando Oliveira · Amanda Alves Rabelo · Beatriz Pastori Vieira de Melo

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-18
https://doi.org/10.17605/osf.io/a4q35